CLSA analysts downgraded Dr. Reddy's Laboratories shares, trading on both BSE (DRRD:IN) and NYSE (NYSE:RDY), from a Hold to an Underperform rating, adjusting the price target from INR1,140 to INR1,090 ...

Despite weak Q3 earnings, Bharat Petroleum (BPCL) draws attention from global brokerages. CLSA upgraded BPCL to ‘Hold’ with a ...

The firm expects mid-single-digit price erosion in generic drugs and heightened competition for key medications, potentially ...

This steady growth in HDFC Bank's core earnings - both NII and net profit - came in despite a marginal rise in NPAs and NPA ...

In a report released on January 21, Garry Sherriff from RBC Capital maintained a Hold rating on Pro Medicus Limited (PMCUF – Research Report), ...

Vikash Kumar Jain, India Strategist and Head of Research at CLSA, predicts 2025 will be a year of consolidation for Indian markets. He noted that the consolidation trend, which began in October, could ...

The brokerage firm has also added Zomato to its high conviction outperform list, saying the recent correction is a buying ...

Shares of Zomato surged as much as 7.27% to reach INR 261.75 during the intraday trading session on the BSE today (January 16 ...

Newmont Corporation (NEM) stock saw a modest uptick, ending the day at $42.35 which represents a slight increase of $0.68 or 1.63% from the prior close of $41.67. The stock opened at $42.11 and ...

CLSA has initiated coverage on Hyundai Motor India with an 'Outperform' rating and a target price of Rs 2,155, citing strong ...

In a report released today, Adrian Lemme from Citi maintained a Buy rating on Coles Group Ltd. (CLEGF – Research Report), with a price target ...